Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration in Japan (vol 12, pg 2005, 2023)Yasuo Yanagi,Kanji Takahashi,Tomohiro Iida,Fumi Gomi, Junko Morii,Eriko Kunikane,Taiji SakamotoOPHTHALMOLOGY AND THERAPY(2023)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要